Cargando…
Antibody response after 2 and 3 doses of SARS-CoV-2 mRNA vaccine in allogeneic hematopoietic cell transplant recipients
Autores principales: | Maillard, Alexis, Redjoul, Rabah, Klemencie, Marion, Labussière Wallet, Hélène, Le Bourgeois, Amandine, D'Aveni, Maud, Huynh, Anne, Berceanu, Ana, Marchand, Tony, Chantepie, Sylvain, Botella Garcia, Carmen, Loschi, Michael, Joris, Magalie, Castilla-Llorente, Cristina, Thiebaut-Bertrand, Anne, François, Sylvie, Leclerc, Mathieu, Chevallier, Patrice, Nguyen, Stephanie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Hematology.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616709/ https://www.ncbi.nlm.nih.gov/pubmed/34818411 http://dx.doi.org/10.1182/blood.2021014232 |
Ejemplares similares
-
Antibody Response to 2-Dose Sars-Cov-2 mRNA Vaccine in Allogeneic Hematopoietic Cell Transplant Recipients
por: Maillard, Alexis, et al.
Publicado: (2021) -
Pre-exposure prophylaxis with tixagevimab/cilgavimab (AZD7442) prevents severe SARS-CoV-2 infection in recipients of allogeneic hematopoietic stem cell transplantation during the Omicron wave: a multicentric retrospective study of SFGM-TC
por: Jondreville, Ludovic, et al.
Publicado: (2022) -
Outcome after allogeneic stem cell transplantation with haploidentical versus HLA-matched donors in patients with higher-risk MDS
por: Michel, Claire, et al.
Publicado: (2023) -
Strategic Capitalism: The New Economic Strategy for Winning the Capitalist Cold War
por: D'Aveni, Richard
Publicado: (2012) -
Choosing Scope Over Focus
por: D'Aveni, Richard
Publicado: (2017)